Dimensional Fund Advisors
MDGL icon

Dimensional Fund Advisors’s Madrigal Pharmaceuticals MDGL Stock Holding History

Dimensional Fund Advisors’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.77M Buy
8,884
+364
+4% +$186K ﹤0.01% 2556
2026
Q1 		$4.46M Sell
8,520
-10,801
-56% -$5.16M ﹤0.01% 2532
2025
Q4 		$11.3M Buy
19,321
+13,522
+233% +$6.91M ﹤0.01% 2239
2025
Q3 		$2.66M Buy
5,799
+1,929
+50% +$720K ﹤0.01% 2698
2025
Q2 		$1.17M Buy
3,870
+26
+0.7% +$7.75K ﹤0.01% 2863
2025
Q1 		$1.27M Buy
+3,844
New +$1.26M ﹤0.01% 2824
2023
Q3 		– Sell
-16,345
Closed -$3.78M – 3492
2023
Q2 		$3.78M Buy
16,345
+44
+0.3% +$11.9K ﹤0.01% 2610
2023
Q1 		$3.95M Buy
+16,301
New +$4.44M ﹤0.01% 2553
2022
Q3 		$2.99M Sell
45,995
-123,299
-73% -$8.57M ﹤0.01% 2593
2022
Q2 		$12.1M Sell
169,294
-46,903
-22% -$3.45M ﹤0.01% 2115
2022
Q1 		$21.2M Buy
216,197
+13,885
+7% +$1.17M 0.01% 1934
2021
Q4 		$17.1M Buy
202,312
+27,900
+16% +$2.29M 0.01% 2069
2021
Q3 		$13.9M Buy
174,412
+5,240
+3% +$453K ﹤0.01% 2177
2021
Q2 		$16.5M Sell
169,172
-3,339
-2% -$395K 0.01% 2132
2021
Q1 		$20.2M Sell
172,511
-16,319
-9% -$1.9M 0.01% 2032
2020
Q4 		$21M Sell
188,830
-10,934
-5% -$1.34M 0.01% 1956
2020
Q3 		$23.7M Buy
199,764
+744
+0.4% +$80.8K 0.01% 1754
2020
Q2 		$22.5M Buy
199,020
+1,342
+0.7% +$132K 0.01% 1815
2020
Q1 		$13.2M Buy
197,678
+12,134
+7% +$1.01M 0.01% 1967
2019
Q4 		$16.9M Buy
185,544
+70,222
+61% +$6.81M 0.01% 2125
2019
Q3 		$9.94M Buy
115,322
+26,146
+29% +$2.45M ﹤0.01% 2339
2019
Q2 		$9.35M Buy
89,176
+71,906
+416% +$7.7M ﹤0.01% 2418
2019
Q1 		$2.16M Buy
17,270
+9,608
+125% +$1.19M ﹤0.01% 2878
2018
Q4 		$862K Sell
7,662
-3,643
-32% -$564K ﹤0.01% 3047
2018
Q3 		$2.42M Buy
11,305
+6,512
+136% +$1.63M ﹤0.01% 2873
2018
Q2 		$1.34M Buy
+4,793
New +$842K ﹤0.01% 2970

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors's MDGL Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Madrigal Pharmaceuticals (MDGL) stake by 4.3% in Q2 2026, buying an estimated $186K and bringing the position to 8,884 shares worth $4.77M. The position accounts for ﹤0.01% of the portfolio, ranked #2556.

Dimensional Fund Advisors first reported a position in MDGL in Q2 2018 and has held it in 26 quarters since. The position peaked at $23.7M in Q3 2020. 413 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Dimensional Fund Advisors held 8,884 shares of Madrigal Pharmaceuticals worth $4.77M as of Q2 2026.
  • Dimensional Fund Advisors bought 364 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $186K.
  • Madrigal Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2556 holding.
  • Dimensional Fund Advisors first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 26 quarters since.
  • Dimensional Fund Advisors's Madrigal Pharmaceuticals position peaked at $23.7M in Q3 2020.
  • 413 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.